Fluidigm Corporation (NASDAQ:FLDM) Q1 2020 Earnings Conference Call May 7, 2020 17:30 ET Company Participants Agnes Lee - Vice President, Investor Relations Chr
Ladies and gentlemen, thank you for standing by, and welcome to the Fluidigm first-quarter 2020 financial results conference call. At the close of the market today, Fluidigm released its financial re
Solar Senior Capital (NASDAQ:SUNS) Q1 2020 Earnings Conference Call May 08, 2020, 11:30 AM ET Company Participants Michael Gross - Chairman & Co-CEO Bruce S
Q1 2020 Fluidigm Corp Earnings Call
First Quarter Revenue Decreased 8 Percent to $27.6 Million New COVID-19 Opportunities for Microfluidics and Mass Cytometry Businesses Customers filing FDA Emergency Use.
Custom Projects and Consultation from Experimental Panel Design to Data Analysis             Providing Instrument Access Prior to Purchase Decision and Much‑Needed Capacity for.
Is (FLDM) Outperforming Other Medical Stocks This Year?
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Apache Corporation, Valero Energy Corporation, Compugen. Read Harry Boxer's latest article on Investing.com
Are These On Your List Of Penny Stocks To Watch In May 2020? May 03, 2020 (Penny Stocks via COMTEX) -- Regardless of which names are on your list of penny...
Fluidigm Co. (NASDAQ:FLDM) saw unusually large options trading on Friday. Traders purchased 2,451 call options on the stock. This represents an increase of 3,352% compared to the typical daily volume
Darpa says its breakthrough technology could be manufactured at large scale
Fluidigm (FLDM +54.0%), fresh off of a volatility halt, is up on more than triple normal volume clearing a five-week base in apparent response to an article in The Guardian about a DARPA-funded COVID-
Exclusive: test has potential to identify carriers before they become infectious and spread the coronavirus
Fluidigm (NASDAQ:FLDM) will be issuing its quarterly earnings data after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter.
The Global Transcriptomics Technologies Market is expected to grow from USD 4,273.05 Million in 2018 to USD 9,648.03 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.33%. Read
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE